NeuroPace Inc. 8-K Filing Report - Key Insights from February 20, 2025

$NPCE
Form 8-K
Filed on: 2025-02-20
Source
NeuroPace Inc. 8-K Filing Report - Key Insights from February 20, 2025

Based on the provided XML section of the financial report, here are the key insights extracted:

  1. Company Information:
  • Name: NeuroPace Inc.
  • CIK Number: 0001528287
  • Nasdaq Ticker Symbol: NPCE
  • Address: 455 N. Bernardo Avenue, Mountain View, CA 94043
  • Contact Number: (650) 237-2700
  1. Filing Details:
  • Filing Type: 8-K (this form is used to report unscheduled material events or corporate changes)
  • Filing Date: February 20, 2025
  1. Stock Information:
  • Common Stock: $0.001 par value per share
  1. SEC Registration:
  • SEC File Number: 001-40337
  • IRS Employer Identification Number (EIN): 22-3550230
  1. Period of Reporting:
  • Reporting Date: The report covers a single day, February 20, 2025.

Insights:

  • The filing is an 8-K, indicating that NeuroPace Inc. may have reported a significant event on that date, which could impact investors or stakeholders.
  • The company is publicly traded on the NASDAQ under the ticker NPCE, which is essential for potential investors tracking the stock.
  • The par value of the common stock is minimal ($0.001), which is common for many companies and does not typically reflect the market price of the stock.

This information provides a snapshot of NeuroPace Inc.'s corporate actions and relevant identifiers for investors and analysts looking to understand the company's current status and recent activities.